Speakers

Grant Blouse

Vice President Translational Research

Catalyst Biosciences

Julianne Bruno

Senior Director

CRISPR Therapeutics

John Chapin

Senior Director

CRISPR Therapeutics

Colleen Dansereau

Director, Clinical Operations, Gene Therapy Program

Boston Children’s Hospital

Mrudula Donepudi

Director, Scientific Communications and Clinical Science

Editas Medicine

Catalina Driscoll

Global Head, New Product Planning, Rare Blood Disorders

Sanofi Genzyme

Dean Falb

Chief Scientific Officer

LogicBio

Meghan Gallagher

Director, Value Demonstration, Market Access

bluebird bio

Nicolas Garnier

Director, Patient Advocacy, Global Product Development

Pfizer Rare Disease

Angela Johnson

Senior Director, Regulatory Affairs

Sigilon Therapeutics

Paul Monahan

Clinical and Translational Lead, Hematology

Spark Therapeutics

Dawn Rotellini

Chief Operating Officer

National Hemophilia Foundation

Eileen Sawyer

Vice President, Global Medical Affairs

uniQure

Julian Down

Senior Director, Gene Therapy

Poseida Therapeutics

Matt Trudeau

Vice President, Commercial Operations

bluebird bio

Sander van Deventer

Executive Vice President, Research and Product Development

uniQure

John Woolley

Principal Investigator

University of Liverpool

Brendan Hayes

Director, External Affairs

National Hemophilia Foundation

Next Page: Full Event GuideClick Here >